THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
Open Access
- 1 November 2003
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 31 (11) , 1279-1282
- https://doi.org/10.1124/dmd.31.11.1279
Abstract
Exposure of the immortalized human breast epithelial cell line MCF10A to the Jun N-terminal kinase (JNK) inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP600125) suppressed, in a concentration-dependent manner (IC50 ∼2 μM), the induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Cotreatment with SP600125 also suppressed the accumulation of TCDD-induced nuclear aryl hydrocarbon receptor (AhR)-DNA complexes, as assessed by electrophoretic mobility shift assays. Concentrations of SP600125 ≤ 50 μM did not transform the AhR into a DNA-binding species when added to rat liver cytosol. However, addition of SP600125 to cytosol just before TCDD addition completely suppressed AhR transformation and DNA binding (IC50 ∼7 μM). Sucrose gradient analyses using rat liver and murine hepatoma 1c1c7 extracts demonstrated that SP600125 competed with TCDD for binding to the AhR. These results suggest that SP600125 is an AhR ligand and functions as an AhR antagonist at concentrations used to pharmacologically inhibit JNK.Keywords
This publication has 29 references indexed in Scilit:
- Characterization of Signaling Pathways Activated by the Interleukin 1 (IL-1) Receptor Homologue T1/ST2Journal of Biological Chemistry, 2002
- Differential Regulation of CD44 Expression by Lipopolysaccharide (LPS) and TNF-α in Human Monocytic Cells: Distinct Involvement of c-Jun N-Terminal Kinase in LPS-Induced CD44 ExpressionThe Journal of Immunology, 2002
- Ligand binding and activation of the Ah receptorPublished by Elsevier ,2002
- Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated CYP1A1 and CYP1B1 induction by 12-O-tetradecanoylphorbol-13-acetate: role of transforming growth factor β and mitogen-activated protein kinasesBiochemical Pharmacology, 2001
- SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinaseProceedings of the National Academy of Sciences, 2001
- Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002)Biochemical Pharmacology, 2000
- Characterization of the Ah Receptor-associated Protein, ARA9Journal of Biological Chemistry, 1998
- Down-regulation of Major Histocompatibility ComplexQ1 Gene Expression by 2,3,7,8-Tetrachlorodibenzo-p-dioxinJournal of Biological Chemistry, 1997
- Analysis of structural requirements for ah receptor antagonist activity: Ellipticines, flavones, and related compoundsBiochemical Pharmacology, 1996
- Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism.Molecular and Cellular Biology, 1993